Benjamin Kolt
About Benjamin Kolt
Ben Kolt is the VP of Data Contributor and Customer Success with over 20 years of experience in data and healthcare, specializing in EHR implementation, population health management, and customer experience.
Ben Kolt's Professional Title
Ben Kolt serves as the Vice President of Data Contributor and Customer Success. In this role, he leverages his extensive experience in data management and customer engagement to drive impactful results in the healthcare sector.
Ben Kolt's Educational Background
Ben Kolt holds a Master's degree in English Rhetoric and Composition from Bowling Green State University in Ohio. He also earned a Bachelor's degree in Secondary Education from the same institution. This educational foundation equips him with unique skills in communication and teaching, which he integrates into his professional endeavors.
Ben Kolt's Experience in Data and Healthcare
With over 20 years of experience working with data, Ben Kolt has made significant contributions to the healthcare industry. He started his career assisting international molecular biologists with identifying novel targets and chemical pathways using computational tools. His expertise includes leading teams for EHR implementation and support, managing value-based care and population health, and transforming caregiver education on EHR usage.
Ben Kolt's Role at IBM Watson Health/Explorys
At IBM Watson Health/Explorys, Ben Kolt led Life Science Clinical Data Products and Customer Experience. He played a critical role in creating client education, customer support, and customer experience teams. His efforts in building data products and supporting sales teams globally significantly improved customer satisfaction and retention.
Ben Kolt's Contributions During the COVID-19 Pandemic
During the COVID-19 pandemic, Ben Kolt collaborated with colleagues to deepen the understanding of the virus. His work with de-identified data provided valuable insights to pharma and life science companies regarding patient conditions and drug effectiveness, helping to inform strategies and responses to the pandemic.